CD8A and neoplasm: Analysis of tumor-infiltrating lymphocytes immediately after the treatment revealed that MDSC (CD11b+Gr1+) counts decreased significantly, but no significant changes were detected in the counts of CD8 T (CD3+CD8+) cells, NK (CD3−NK1.1+) cells, and macrophages (CD11b+ F4/80+) (figure 2H).